Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common diabetes drug ease fibromyalgia pain?

NCT ID NCT05900466

First seen Mar 31, 2026 · Last updated Jun 22, 2026 · Updated 9 times

Summary

This study tests whether low-dose metformin, a common diabetes drug, can improve fibromyalgia symptoms by reducing inflammation in the body. Researchers will give 72 adults with fibromyalgia either metformin or a placebo daily for 8 weeks. The goal is to see if metformin safely reduces pain and other symptoms better than a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84132, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Metformin (low-dose extended-release tablets)

What this could lead to

If it works, this could point toward a new, affordable treatment option for fibromyalgia that targets inflammation.

What could go wrong

This is a small, early proof-of-concept study. Metformin may not improve symptoms more than placebo, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.